P/sunny
67°
P/sunny
Hi 71° | Lo 39°

Mass. senate eyes easier access to addiction treatment

Pharmacists would substitute abuse-deterrent drugs for non-abuse deterrent formulas, physicians would need to receive training on the state’s prescription monitoring program before renewing their license, and insurance carriers would face coverage requirements for drug and alcohol treatment under a new Senate plan aimed at curbing drug addiction problems in Massachusetts.

The plan calls for a new certification process for drug and alcohol treatment centers, with insurers banned from requiring prior authorization for anyone seeking services from a certified center.

It removes prior authorization for acute treatment services for all commercial insurance carriers and requires coverage up to 21 days. It also removes prior authorization for acute treatment services for all MassHealth Managed Care entities, and requires coverage up to 15 days of clinical services.

Insurance carriers would be required to provide reimbursement for substance abuse treatment services delivered by a licensed alcohol and drug counselor.

“This is a bold move, and we know it,” Senate President Therese Murray said about the overall plan, which was released Thursday morning with an announcement that a Senate vote is planned for Tuesday.

“We have to break the cycle of addiction before it breaks us, and the time to act is now,” Murray added.

Sen. Stephen Brewer (D-Barre) said costs associated with the proposals will be rolled out in the Senate’s version of the fiscal year 2015 budget, expected to be unveiled next week.

Murray said the bill will also deal with mental health parity and the need for more mental health beds.

“We will have a budget that comes out next week that will reflect our interest in opening more community-based beds as well as opening more beds in the new institution that we have in Worcester,” Murray said. “So we will be putting our money, your money, where it should be.”

The plan is the culmination of work of a special Senate committee created in January to look at the opiate epidemic in the state and evaluate the drug treatment process and detox programs in the wake of an uptick of the number of people civilly committed by the courts for drug addiction.

Under the plan, a commission will create lists of drugs that are abuse deterrent that are similar to non-abuse deterrent ones.

The mandatory substitution of abuse-deterrent drugs will not only address Zohydro ER — which Gov. Deval Patrick attempted to ban because it is an opiate that is not tamper-proof — but other drugs that fall into the same category, Sen. John Keenan (D-Quincy) said. Insurance carriers will be required to cover the substitute drug like any other.

“When a physician writes a prescription and that prescription goes to a pharmacy, the pharmacist will have the ability to substitute the abuse-deterrent drug off the formulary for the non-abuse deterrent drug,” Keenan said. “So when you have a very dangerous non-abuse deterrent drug that is prescribed we will now have a way for a pharmacist to substitute that so a patient is getting a drug that is less capable of being crushed, melted, whatever the case may be, and less capable of being abused.”

Other elements of the proposal:

∎ Directs the Center for Health Information and Analysis to review denial rates for substance abuse treatment coverage by commercial insurers.

∎ Creates a commission to review prescription painkiller limitations by insurance carriers.

∎ Requires the Department of Public Health to list locations of prescription drug drop boxes on its website and submit a list of counties without prescription drug drop boxes to the Legislature.

∎ Directs the Center for Health Information and Analysis to review the accessibility of substance abuse treatment and the adequacy of private insurance coverage. It tasks the Health Policy Commission with recommending policies to ensure access and coverage for substance abuse treatment.

How about the Government start allowing terminally ill patients to be treated with controversial drugs, namely marijuana oil which has been shown to stop the growth of cancer cells in mice? These people are not going to care if they get high during the course of treatment, these people deserve every chance they have to live. I've have been looking for a research program that is taking human subjects but am unable to find one. This is crazy! Is the only thing stopping them the fact that the patient is going to get stoned?

Post a Comment

You must be registered to comment on stories. Click here to register.